KemPharm

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KemPharm and buy or sell other stocks, options, and ETFs commission-free!

About KMPH

Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. 

CEO
Neil F. McFarlane
CEONeil F. McFarlane
Employees
36
Employees36
Headquarters
Celebration, Florida
HeadquartersCelebration, Florida
Founded
2006
Founded2006
Employees
36
Employees36

KMPH Key Statistics

Market cap
213.83M
Market cap213.83M
Price-Earnings ratio
-5.01
Price-Earnings ratio-5.01
Dividend yield
Dividend yield
Average volume
256.02K
Average volume256.02K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$7.28
52 Week high$7.28
52 Week low
$3.89
52 Week low$3.89
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.